Explore clinical outcomes of switching NTI drugs to generics. Learn about bioequivalence gaps, risks for warfarin and epilepsy meds, and expert monitoring tips.
Read MoreExplore clinical outcomes of switching NTI drugs to generics. Learn about bioequivalence gaps, risks for warfarin and epilepsy meds, and expert monitoring tips.
Read MoreState laws on NTI drug substitution vary widely across the U.S., with 27 states restricting generic swaps for medications like warfarin and levothyroxine. While the FDA says generics are safe, patient safety concerns are driving state-level rules - and a national shift is coming.
Read MoreGeneric drugs are identical in active ingredients but vary wildly in price and availability worldwide due to regulatory, economic, and cultural differences. Learn why the same pill costs $1 in India and $100 in the U.S.
Read More